Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04142060 |
| Title | Targeting PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-Positive/Her2-Negative Metastatic Breast Cancer (ARIANNA) |
| Acronym | ARIANNA |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | SOLTI Breast Cancer Research Group |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| ICO Badalona | Badalona | Barcelona | Spain | Details | ||
| Institut Català d'Oncologia Hospitalet | Hospitalet de Llobregat | Barcelona | Spain | Details | ||
| Hospital Clinic de Barcelona | Barcelona | Spain | Details | |||
| Hospital Universitari Vall d' Hebrón | Barcelona | Spain | Details | |||
| Hospital Universitario 12 de Octubre | Madrid | 28041 | Spain | Details | ||
| Hospital Universitario Fundación de Alcorcón | Madrid | Spain | Details | |||
| Hospital Universitario Virgen del Rocio | Sevilla | Spain | Details | |||
| Fundación Instituto Valenciano de Oncología | Valencia | 46009 | Spain | Details |